Edesa Biotech, Inc.
EDSA • NASDAQ
Edesa Biotech, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Pardeep Nijhawan, with a market cap of $48.6M.
CEOPardeep Nijhawan
Next Earnings
Upcoming earnings announcement for Edesa Biotech, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.26
Earnings History
Past 12 earnings reports for Edesa Biotech, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Q1 2026 | -$0.28Est: -$0.38 | +26.3% | - | — |  10-Q |
| Dec 12, 2025 | Q4 2025 | -$0.32Est: -$0.27 | -18.5% | - | — | 10-K |
| Aug 8, 2025 | Q3 2025 | -$0.25Est: -$0.25 | 0.0% | - | — | 10-Q |
| May 14, 2025 | Q2 2025 | -$0.30 | — | - | — | 10-Q |
| Feb 14, 2025 | Q1 2025 | -$0.48 | — | - | — | 10-Q |
| Dec 13, 2024 | Q4 2024 | -$0.29Est: -$0.54 | +46.3% | - | — | 10-K/A |
| Aug 9, 2024 | Q3 2024 | -$0.52Est: -$0.58 | +10.3% | - | — | 10-Q |
| May 10, 2024 | Q2 2024 | -$0.58Est: -$0.69 | +15.9% | - | — | 10-Q |
| Feb 9, 2024 | Q1 2024 | -$0.54Est: -$1.21 | +55.4% | -Est: - | — | 10-Q |
| Dec 15, 2023 | Q4 2023 | -$0.55Est: -$0.71 | +22.5% | - | — | — |
| Aug 9, 2023 | Q3 2023 | -$0.70Est: -$1.19 | +41.2% | - | — | — |
| May 11, 2023 | Q2 2023 | -$0.84Est: -$1.19 | +29.4% | - | — | — |